Ticlopidine+Ginkgo Biloba Versus Clopidogrel in Clopidogrel Resistant Patients Undergoing Cartoid Artery Stent Placement (CRECAS)

NCT02133989 Phase 3 UNKNOWN

The purpose of this study is to evaluate the efficacy and safety of the ticlopidine + ginko biloba compared to clopidogrel in clopidogrel resistant patients undergoing carotid artery stent placement. The investigators hypothesized that ticlopidine + ginko biloba is superior than clopidogrel in terms of post-stent ischemic lesions in these patients without serious complications.

Details

Lead sponsor	Samsung Medical Center
Phase	Phase 3
Status	UNKNOWN
Enrolment	86
Start date	2014-06
Completion	2017-12

Conditions

• Carotid Stenosis

Interventions

• Ticlopidine + Ginko biloba
• Clopidogrel

Primary outcomes

• New ischemic lesion on diffusion-weighted imaging (DWI) — within 24 hours after carotid stenting
  Presence of new ischemic lesion in the ipsilesioinal hemisphere on DWI after carotid stening

Countries

South Korea